Breo Ellipta: An inhaled fluticasone/ vilanterol combination for COPD

Medical Letter on Drugs and Therapeutics

Volumn 55, Issue 1424, 2013, Pages 69-71

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

ACLIDINIUM BROMIDE; ARFORMOTEROL; BUDESONIDE PLUS FORMOTEROL; FLUTICASONE FUROATE PLUS VILANTEROL; FLUTICASONE PROPIONATE PLUS SALMETEROL; FORMOTEROL FUMARATE; INDACATEROL; KETOCONAZOLE; PLACEBO; ROFLUMILAST; SALMETEROL XINAFOATE; SPIRIVA HANDIHALE; TIOTROPIUM BROMIDE; UNCLASSIFIED DRUG; BENZYL ALCOHOL DERIVATIVE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; BRONCHODILATING AGENT; CHLOROBENZENE; DRUG COMBINATION; FLUTICASONE; VILANTEROL;

ASTHMA; BONE DENSITY; CATARACT; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE EXACERBATION; FRACTURE; GLAUCOMA; HEADACHE; HUMAN; INCIDENCE; LETTER; LUNG FUNCTION; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RHINOPHARYNGITIS; SIDE EFFECT; THRUSH; UPPER RESPIRATORY TRACT INFECTION; DRUG COMBINATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE;

ADRENERGIC BETA-2 RECEPTOR AGONISTS; BENZYL ALCOHOLS; BRONCHODILATOR AGENTS; CHLOROBENZENES; DRUG COMBINATIONS; FLUTICASONE; HUMANS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84883321510     PISSN: 0025732X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (7)

1. Drugs for asthma and COPD. Treat Guidel Med Lett 2013; 11:75.
2. FJ Martinez et al. Fluticasone furoate/vilanterol (100/25; 200/25 mcg) improves lung function in COPD: a randomized trial. Respir Med 2013; 107:550.
3. EM Kerwin et al. A randomized trial of fluticasone furoate/vilanterol (50/25 mcg; 100/25 mcg) on lung function in COPD. Respir Med 2013; 107:560.
4. MT Dransfield et al. Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials. The Lancet Respiratory Medicine 2013; 1:210.
5. FDA medical review. Breo Ellipta (fluticasone furoate and vilanterol trifenatate) inhalation powder. Available at http://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204 275Orig1s000TOC.cfm. Accessed August 21, 2013.
6. R Kempsford et al. The effect of ketoconazole on the pharmacokinetics and pharmacodynamics of inhaled fluticasone furoate and vilanterol trifenatate in healthy subjects. Br J Clin Pharmacol 2013; 75:1478.
7. Inhibitors and inducers of CYP enzymes and P-glycoprotein. Med Lett Drugs Ther 2013; 55:e44.